» Authors » Xinhui Zhou

Xinhui Zhou

Explore the profile of Xinhui Zhou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 879
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Zhang F, Zhou X, Shen X, Niu Q, Yang T
Opt Express . 2024 Nov; 32(17):30632-30641. PMID: 39573219
Computational spectrometers are explored to overcome the disadvantages of large size, narrow bandwidth and low spectral resolution suffered by conventional spectrometers. However, expensive spectral encoders and unstable algorithms impede widespread...
2.
Liang H, Zhou X, Zhang J, Xu W, Liu Y, Wang X, et al.
Mol Med . 2024 Nov; 30(1):206. PMID: 39521994
Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by motor neuron loss leading to muscle weakness and atrophy. Apigenin (APG), known for its antioxidant properties, holds potential...
3.
Zhu L, Zhou X, Ma L, Hu Y
Hormones (Athens) . 2024 Jun; 23(4):821-829. PMID: 38872063
Purpose: Aromatase plays an important role in ovarian development, the normal progress of the menstrual cycle, and fertility status. Elevated aromatase activity is linked to obesity. There is a bidirectional...
4.
Li F, Zhou X, Hu W, Du Y, Sun J, Wang Y
Future Sci OA . 2024 Jun; 10(1):FSO936. PMID: 38827797
Our research aimed to determine an optimal cutoff value and investigate the prognostic predictive function of Ki-67. We retrospectively enrolled 1146 patients diagnosed with stage I-II triple-negative breast cancer. Disease-free...
5.
Powell R, Rinkenbaugh A, Guo L, Cai S, Shao J, Zhou X, et al.
NPJ Breast Cancer . 2024 May; 10(1):37. PMID: 38802426
Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases in the United States. Systemic neoadjuvant chemotherapy (NACT), with or without immunotherapy, is the current standard of care...
6.
Wang Y, Peng D, Zhou X, Hu W, Li F
Clin Breast Cancer . 2023 Nov; 24(2):122-130.e2. PMID: 38016910
Introduction: With progress in treatments, breast ductal carcinoma in situ (DCIS) outcomes have substantially improved. However, as various treatment methods are used in different countries and institutions, consensus on the...
7.
Zhu S, Wang Q, Wang X, Pan J, Yang T, Zhou X, et al.
Inorg Chem . 2023 Sep; 62(40):16589-16598. PMID: 37757754
A luminescent 1D coordination polymer (CP) [ZnL(HO)]·HO (, HL = 1-(4-carboxyphenyl)-1-pyrazole-3-carboxylic acid) was prepared by a solvothermal method. shows excellent fluorescence properties and has an obvious fluorescence "turn-on" phenomenon for...
8.
Ren W, Wang H, Du Y, Li Y, Feng Z, Zhou X, et al.
Front Plant Sci . 2023 Jul; 14:1213807. PMID: 37416884
Heavy ion beam (HIB) is an effective physical mutagen that has been widely used in plant mutational breeding. Systemic knowledge of the effects caused by different HIB doses at developmental...
9.
Hua T, Li D, Li X, Lin J, Niu J, Cheng J, et al.
Environ Res . 2022 Sep; 215(Pt 3):114433. PMID: 36167114
Here, we report a novel amino-modified mesoporous-structured aluminum-based metal-organic framework adsorbent, MIL-68(Al)/MCM-41-NH, for dye sewage treatment. The introduction of molecular sieves overcomes the inherent defects of microporous MOFs in contaminant...
10.
Yang X, Liu Y, Zhou X, Chen K, Xu J, Xu S
Transl Oncol . 2022 Sep; 25:101515. PMID: 36087384
Noncoding RNAs (ncRNAs) play important roles in cancer biology, providing potential targets for cancer intervention. As a new class of endogenous noncoding RNAs, circular RNAs (circRNAs) have been recently identified...